Medical Dosimetry
Volume 36, Issue 4 , Pages 344-346 , Winter 2011

Novel Use of the Contura for High Dose Rate Cranial Brachytherapy

  • Daniel J. Scanderbeg, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of California at San Diego, La Jolla, CA
    • Center for Advanced Radiotherapy Technologies, Rebecca and John Moores Comprehensive Cancer Center, University of California at San Diego, La Jolla, CA
    • Corresponding Author InformationReprint requests to: Daniel J. Scanderbeg, Ph.D., Department of Radiation, Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Dr. #0843, La Jolla, CA 92093-0843
    • ,
  • John F. Alksne, M.D.

      Affiliations

    • Division of Neurological Surgery, University of California at San Diego, La Jolla, CA
    • ,
  • Joshua D. Lawson, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California at San Diego, La Jolla, CA
    • Center for Advanced Radiotherapy Technologies, Rebecca and John Moores Comprehensive Cancer Center, University of California at San Diego, La Jolla, CA
    • ,
  • Kevin T. Murphy, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California at San Diego, La Jolla, CA

Received 26 February 2010 ,Accepted 16 August 2010.

References 

  1. Walker MD, Green SB, Byar DP, et al. Randomized comparision of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery: BTSG 72-01. N. Engl. J. Med. 1980;303:1323–1327
  2. Glioma Meta-analysis Trialists Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet. 2002;359:1011–1018
  3. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolmide for glioblastoma. N. Engl. J. Med. 2005;352:987–996
  4. Lee SW, Fraass BA, Marsh LH, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:79–88
  5. Sneed PK, Gutin PH, Larson DA, et al. Patterns of recurrence of glioblastoma multiforme after external radiation followed by implant boost. Int. J. Radiat. Oncol. Biol. Phys. 1994;29:719–727
  6. Sneed PK, Lamborn KR, Larson DA, et al. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:37–44
  7. Tatter SB, Shaw EG, Rosenblum ML, et al. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial. J. Neurosurg. 2003;99:297–303
  8. Gabayan AJ, Green SB, Sanan A, et al. GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery. 2006;58:701–708
  9. Chino K, Silvain D, Grace A, et al. Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System. Med. Phys. 2008;35:3383–3388
  10. Welsh J, Sanan A, Gabayan AJ, et al. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: A retrospective multi-institutional pilot study. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:159–165
  11. Tselis N, Kolotas C, Birn G, et al. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Strahlentherapie. und. Onkologie. 2007;183:563–570
  12. Fabrini MG, Perrone F, De Franco L, et al. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlentherapie. und. Onkologie. 2009;185:524–539

PII: S0958-3947(10)00127-5

doi: 10.1016/j.meddos.2010.08.001

Medical Dosimetry
Volume 36, Issue 4 , Pages 344-346 , Winter 2011

Article Tools

* Image Usage & Resolution